Serum Lipids and Plasma Glucose in Women on Hormonal-Based Contraceptives

Hormonal-based contraceptives (HCs) available as oral (OCs) and injectable (ICs), have gained wide acceptance worldwide including developing countries like Nigeria due to their high efficacy in preventing pregnancy. However, they are associated with increased risks for certain metabolic diseases. In...

Full description

Saved in:
Bibliographic Details
Main Author: Abdullahi, H.L.*, Saleh, A.A., Mohammed, I.Y., Yahaya, I.S., Abdullahi, T.M.
Format: Article
Language:English
Published: Hammer Head Production Limited 2018-06-01
Series:Sokoto Journal of Medical Laboratory Science
Subjects:
Online Access:https://sokjmls.com.ng/index.php/SJMLS/article/view/260
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850279046073548800
author Abdullahi, H.L.*, Saleh, A.A., Mohammed, I.Y., Yahaya, I.S., Abdullahi, T.M.
author_facet Abdullahi, H.L.*, Saleh, A.A., Mohammed, I.Y., Yahaya, I.S., Abdullahi, T.M.
author_sort Abdullahi, H.L.*, Saleh, A.A., Mohammed, I.Y., Yahaya, I.S., Abdullahi, T.M.
collection DOAJ
description Hormonal-based contraceptives (HCs) available as oral (OCs) and injectable (ICs), have gained wide acceptance worldwide including developing countries like Nigeria due to their high efficacy in preventing pregnancy. However, they are associated with increased risks for certain metabolic diseases. In this study, a total of 200 participants were randomly recruited for the study made up of 100 women on contraceptive (subjects) and 100 non-contraceptive users (controls) The mean age and BMI of the subjects was 28.97 ± 7.18 years and 24.61 ± 5.30 respectively. There were significant differences (p<0.05) between the mean values of fasting glucose (FG) (4.58 ± 1.10 mmol/L vs. 3.9 ± 0.57mmol/l), total cholesterol (TC) (4.75 ± 0.68mmol/L vs. 3.98 ± 0.74 mmol/L), triglyceride (TG) (1.16 ± 0.28mmol/L vs. 1.35 ± 0.31mmol/L), high density lipoprotein(HDL-C) (1.62 ± 0.35mmol/L vs. 1.13 ± 0.33mmol/L) and low density lipoprotein(LDL-C) (2.65 ± 045mmol/L vs. 2.14 ± 0.59mmol/L) of women on HCPs and that of control group. No significant differences (p>0.05) were observed between the mean values of plasma FG (6.94 ± 6.85mmol/L vs. 5.15 ± 1.20mmol/L), serum TC (5.72 ± 1.53mmol/L vs. 5.23 ± 1.24mmol/L), serum TG (1.19 ± 0.98mmol/l vs. 1.14 ± 0.82mmol/l) as well as serum LDL-C (3.47 ± 1.28mmol/l vs. 3.41 ± 1.21mmol/L) of OC and IC users respectively. However, a significant difference was observed between mean values of serum HDL-C (1.70 ± 0.73mmol/l vs. 1.37 ± 0.37mmol/l respectively) between OC and IC users. No significant difference (p<0.05) was observed on the basis of duration of use of HCs. The results of this study further emphasize the need for caution and routine regular check-up when using HCs in order to prevent complications and the adverse side effects associated with their use.
format Article
id doaj-art-9ee4b04c54cc47aa80b722bf2b26c403
institution OA Journals
issn 2536-7153
language English
publishDate 2018-06-01
publisher Hammer Head Production Limited
record_format Article
series Sokoto Journal of Medical Laboratory Science
spelling doaj-art-9ee4b04c54cc47aa80b722bf2b26c4032025-08-20T01:49:14ZengHammer Head Production LimitedSokoto Journal of Medical Laboratory Science2536-71532018-06-0132260Serum Lipids and Plasma Glucose in Women on Hormonal-Based ContraceptivesAbdullahi, H.L.*, Saleh, A.A., Mohammed, I.Y., Yahaya, I.S., Abdullahi, T.M.Hormonal-based contraceptives (HCs) available as oral (OCs) and injectable (ICs), have gained wide acceptance worldwide including developing countries like Nigeria due to their high efficacy in preventing pregnancy. However, they are associated with increased risks for certain metabolic diseases. In this study, a total of 200 participants were randomly recruited for the study made up of 100 women on contraceptive (subjects) and 100 non-contraceptive users (controls) The mean age and BMI of the subjects was 28.97 ± 7.18 years and 24.61 ± 5.30 respectively. There were significant differences (p<0.05) between the mean values of fasting glucose (FG) (4.58 ± 1.10 mmol/L vs. 3.9 ± 0.57mmol/l), total cholesterol (TC) (4.75 ± 0.68mmol/L vs. 3.98 ± 0.74 mmol/L), triglyceride (TG) (1.16 ± 0.28mmol/L vs. 1.35 ± 0.31mmol/L), high density lipoprotein(HDL-C) (1.62 ± 0.35mmol/L vs. 1.13 ± 0.33mmol/L) and low density lipoprotein(LDL-C) (2.65 ± 045mmol/L vs. 2.14 ± 0.59mmol/L) of women on HCPs and that of control group. No significant differences (p>0.05) were observed between the mean values of plasma FG (6.94 ± 6.85mmol/L vs. 5.15 ± 1.20mmol/L), serum TC (5.72 ± 1.53mmol/L vs. 5.23 ± 1.24mmol/L), serum TG (1.19 ± 0.98mmol/l vs. 1.14 ± 0.82mmol/l) as well as serum LDL-C (3.47 ± 1.28mmol/l vs. 3.41 ± 1.21mmol/L) of OC and IC users respectively. However, a significant difference was observed between mean values of serum HDL-C (1.70 ± 0.73mmol/l vs. 1.37 ± 0.37mmol/l respectively) between OC and IC users. No significant difference (p<0.05) was observed on the basis of duration of use of HCs. The results of this study further emphasize the need for caution and routine regular check-up when using HCs in order to prevent complications and the adverse side effects associated with their use.https://sokjmls.com.ng/index.php/SJMLS/article/view/260hormonal contraceptive, plasma glucose, serum lipid profile.
spellingShingle Abdullahi, H.L.*, Saleh, A.A., Mohammed, I.Y., Yahaya, I.S., Abdullahi, T.M.
Serum Lipids and Plasma Glucose in Women on Hormonal-Based Contraceptives
Sokoto Journal of Medical Laboratory Science
hormonal contraceptive, plasma glucose, serum lipid profile.
title Serum Lipids and Plasma Glucose in Women on Hormonal-Based Contraceptives
title_full Serum Lipids and Plasma Glucose in Women on Hormonal-Based Contraceptives
title_fullStr Serum Lipids and Plasma Glucose in Women on Hormonal-Based Contraceptives
title_full_unstemmed Serum Lipids and Plasma Glucose in Women on Hormonal-Based Contraceptives
title_short Serum Lipids and Plasma Glucose in Women on Hormonal-Based Contraceptives
title_sort serum lipids and plasma glucose in women on hormonal based contraceptives
topic hormonal contraceptive, plasma glucose, serum lipid profile.
url https://sokjmls.com.ng/index.php/SJMLS/article/view/260
work_keys_str_mv AT abdullahihlsalehaamohammediyyahayaisabdullahitm serumlipidsandplasmaglucoseinwomenonhormonalbasedcontraceptives